Devonian Health Group Inc

Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The company is headquartered in Montmagny, Quebec and currently employs 8 full-time employees. The firm is to develop prescription drugs for the treatment of fibroinflammatory autoimmune diseases including but not limited to atopic dermatitis, radiodermatitis and ulcerative colitis. The company is also involved in the development of cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its Thykamine is an active lead drug candidate with safety and profiles confirmed in several pre-clinical and clinical studies targeting inflammation. Its cosmeceutical products include R-Spinasome and Purgenesis. The Company’s subsidiary, Altius Healthcare LP, focused on selling prescription pharmaceutical products in Canada, under licenses from brand-name pharmaceutical companies.